SensiGene Cystic Fibrosis (CF) Carrier Screening Test

Friday, 20 November, 2009 | Supplied by: Agena Bioscience Inc


The SensiGene Cystic Fibrosis (CF) Carrier Screening Test screens for 103 mutations and five variants, including the 23 mutations recommended by the American College of Medical Genetics (ACMG).

The test has been shown to identify each of the 103 mutations and five variants through genomic DNA and DNA control testing and offers good detection rates and broader ethnic coverage when compared to the standard ACMG 23 recommended mutations panel.

Because of the increased difficulty in assigning a single ethnicity to an individual, expanded CF panels can provide increased sensitivity for CF carrier screening for many individuals. Having a more comprehensive mutation panel is important as one in 17 CF carriers may be missed using a standard ACMG 23 CF carrier screening panel.

The test employs the MassArray system, which allows direct and label-free analysis of nucleic acids.

Online: agenabio.com
Phone: 07 3088 1600
Related Products

Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium

The products provide researchers and manufacturers with high-performance, scalable and...

Grace Bio-Labs protein microarray tools

Grace Bio-Labs' microarray substrates provide high binding capacity and enable high assay...

Siemens Healthineers 3gAllergy assay

Siemens Healthineers has expanded its 3gAllergy assay menu with nine additional component...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd